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8:3O 
~' -~ Imnt~diate and Late Outcome After Carotid 
Angioplasty (PTA) end Stenting 
Sanlay S. Yadav, Gary S. Roabin, Sdram S. lyer, Peter King, J. 
Michael Parks, Suresh R Jain, Chdstopher Goods, Jid Vitek, Roneld 
L. Levine. University of Alabama at Birmingham, Birmingham, AL 
From 9/8/94 to 8/30/95, 85 pts, (55 symptomatic) had 96 carotid artedes 
treated in an IRB approved single-center, prospective study evaluating the 
immediate and long term efficacy of percuteneous carotid PTA end stenting. 
Symptomatic end asymptomatic pts. with > 60% carotid stenosis were 
eligible. The protocol required independent neurological evaluation pre- and 
post-procedure, at 6 weeks and 6 months and carotid angiography at 6 
months, 
Results: Angiographlc success was 99%; 100=/o had successful stem de- 
ployment and stem thrombosis was 0%. Doe hundred forty-six stents (120 
Johnson & Johnson, Inc., 26 Cook, Inc.) wore deployed for a mean stem to 
artery ratio of 1.5 (range 1 to 6). Mean stenosls was reduced from 74% .4-14% 
to 3% :E 16%. There were no major procedural strokes, MIs or deaths. There 
were 5 (5%) minor (complete recovery within 7 days) procedural strokes and 
1 (1%) major in-hospital stroke secondary to atrial fibrillation. There was 1 
death secondary to ratro-peritoneal b eeding. Twenty-two pts. have reached 
the 6 month engiography endpoim with a mean stenosis of 12% -4- 16=/o 
(range - 7 to 57°/=) and I case of restenosis. Deformation of the stem ends 
was noted in 5 pts, and in 1 pt. repeat balloon dilatation was performed. Late 
neurologic events have not occurred. Two pts. have died in follow-up from 
non-cerebrovascular causes. 
Conclusion: Carotid angioplasty and stentiog is associated with a high 
immediate success rate and a modest complication rate. Angiographic follow- 
up to date shows a low incidence of rest:nosis. 
8:45 
Stenting of  Unprotected Left Main Coronary Artery 
Stenosis Without Coumadln 
Jean Fajadet, Philippe Brunet, Chd~,:ian Jordan, Bernard Cassagneau, 
Jean Marco. Clinique Pastet~; Toulouse, France 
Left main coronen/artew (LMCA) disease is considered as an absolute 
indication for bypass surgery. However, particular situations unfevourable 
to CABG can lead to PTCA attempt. The aim of this study is to determine 
whether stent (S) implantation with the new S management (high pressures 
for S delivery, ant[platelat regimen with Aspidn and Tidopldine, and without 
Coumadin) can be used for the treatment of LMGA stenoses. 
Unprotected LMCA S implantation was performed In 26 consecutive pa- 
tients (pts) treated with Aapidn (100 Pg/day) and Tlclupldine (250 rag/day): 
23 males, mean age of 68.2 ± 10.6 years, 20 pts had unstable angina, LVEF 
was 54.3 4- 11%, 8 pts had two vessel disease, 18 pts had three vessel 
disease. Stsnting was elective in 17 pts and non elective in 9 pts. LMCA 
stenting was achieved suCCessfully in all pts with balloon inflation pressure 
> 16 Arm. Thirteen pts received Palmaz-Schatz S, 11 pts Gienturee Roubin 
S and 2 pts AVE S. No acute or subacute thrombosis occurred. No major 
cardiac events (repeat PTCA, CABG, myocardial infarction, death) occurred 
dudng hospital stay. Clinical follow-up obtained in all pts, 7 rponths (1-24 
months) after the procedure, showed: repeat PTCA for restenosis In 5 pts, no 
CABG or myocardial infarction, sudden death in one 10t, 2 pts had frm~onel 
class 2 angina and 23 tots had no symptoms. 
Conclusion: Unprotected LMCA atenting, using high pressures for $ deliv- 
ery and combination of Aspidn and Ticlopidine can be considered as feasible, 
safe and effective coronary revasculadzation procedure in selected pts who 
are poor candidates for CABG. 
9:00 
Stenting in Protected and Unprotected Left Main 
coronary  Artery: Immediate and Fol low-Up Results 
Akira Itoh, Antonio Colombo, Patrick Hall, Luigi Malello, Carlo Di Mario, 
Simonetta Blengino, Masalmo Ferraro, Giovanni Martini, Lucia Di 
Frencesco, Leo Finci. Columbus HospitN, Milan, Italy 
PTCA of the left main coronmy artery (LM) has been associated with a 
poor clinical follow-up results. We analyzed our results of coronery stem 
implantation i  the LM from the entire stent group of 1679 lots. A total of 33 
patients were treated with 38 Palmaz-Schatz stents and 5 AVE stents. In 15 
patients an unprotected LM lesion were treated and 18 pts had a functioning 
bypass conduit on another vessel (protected LM). The indications for ster~ng 
were elective for 27 lots, dissection for 3 pts, and suboptimal result after 
balloon engioplasty for 3 pts. Angiogrephic success was achieved in 31 pts 
(94%). An emergency CABG during stem implantation was done in I pt, and 
1 pt had an unsuccessful stent deployment. Table shows the engiographic 
results: 
Baseline Post-Steflt Follow-Up 
MLD (mm) 1.37 ± 0.76 3.58 d: 0.60 2.48 4. 0.B9 
Diameter Stenosis (%) 634.18 4±6 324.22 
Aogiographic follow-up was performed in 15 patients (48% of eligiole 
patients). Restenosis by 50% diameter stenosis oriteda occurred in 2 lesions 
(13%). Clinical follow-up was available in all patients at a mean intewal of 
20 ± 12 months. There were 3 deaths within 3 months of the procedure: 2
of them due to LM closure preceded by unstable angina and 1 of uncertain 
cause. Two other patients died during the 2 yearn fellow-up because of 
malignancy. 
Conclusion: W'dh the technology presently available stanting of LM lesions 
carries a high short term risk and should be restricted to selected patients 
who am not considered optimal surgical candidates. 
9:15 
~ ' ~  Coronary Stenting of Bifurcation Lesions:  
Immediate and Follow-Up Results 
Antonio Colombo, Lulgi Malello, Akira Itoh, Patrick Hall. Carlo Di Mado, 
Slmonefta Blengino, Massimo Ferram, Giovanni Martini, Lucia Di 
Francesco, Lee RnoL Columbus Hospital, Milan, Italy 
The transcatheter treatment of lesions at coronary bifurcation is a subject 
of controversy. This study evaluated immedmte nd long-term efficacy of 
stent implentation in such lesions. We treated 38 major bifurcation lesions 
in 34 patients (mean age 61 ± 10 years). The lesion disth'bution was: 16 
LAD-Diag, 11 RCA (PD-PL), 7 LCX-OM, 4 LAD-LCX. Stem indications were: 
31 elective (79%), 1 restenosis (3%), 2 suboptimal PTCf.. and 4 dissection 
after PTCA. Patients were divided into two groups according to the 5tenttng 
sVatogy. Group I (h = 18): stestiog on beth vessels involved in the bifurcation 
lesion; Group II (n = 20): stenting on one vessel and balloon (Idsaiog) dilation 
of the other vessel. Table shows procedural and follow-up data: 
Group I Group II 
Successful stsnting 16 (89%) 19 (95%) 
Stent per patient 2.5 4. 2.0 1.5 4-1.1 
Procedural compllcstlons 2 (11%) 1 (5%) 
Stent hrombosis 1 (6%) I (5%) 
Death at I month 1 (6%) 0 
Conclusion: Stsming of bifurcation lesions was confronted with technical 
complexity and a relatively high event rate after the procedure in this small 
cohort. Improvements in stem design may be necessary to overcome some 
of these limitations. 
9:30 
~ " ~  Multivessel Palmaz-Schatz Stspting: Acute Results 
and Long-Term Outcome 
Roger J. Laham, Aaron D, Bermen, Richard E. I~untz, Donald S. Balm, 
David J. Cohen, Joseph R Carrozza, Harvard Medical School, Beth Israel 
Hospital, Boston, MA 
Palmaz-Schalz stenting (PSS) has been approved for the treatment of de- 
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novo single vessel disease. However, the use of PSS for multivessel~oronary 
disease has not been well defined. Between 1118/90 and 1/3/95, 53 Pts 
(45 men end 8 women) underwent placement of 112 PSS (73 coronary 
and 39 biliary Stents) in 107 vessels (two vessels in 52 Pts and 3 vessels 
in 1 pt). The mean age was 62.4- 11 years. The majodty ot Pta (66°/o) 
had both vessels trcmted uring the same procedure, while 24"/0 underwent 
Staged (within 1 week) slanting and 20% had the 2nd vessel slanted 7.6 
:1:9.3 months later. 32 Pte (60%) had HTN and 23 Pts (43%) had diabetes 
mallltus. 43 Pts (53%) presented with unstable angina, 11 Its (21%) had a 
recent myocardial infarction and 41 pta ('/9%) had prior CABG. The vessels 
stented wore the LAD (7%), LCX (6%), RCA (P/o), and venous bypass grafts 
(80%). 8tenfing was successful in 52 Pts (g~,=). The mean pra-proeedural 
% stenosis was 72.4- 37 and the mean pest-precedurel % stenoals was 
2 ~ 2. No pt died in-hospital or had emergency CABG. 6 Pts (11%) had 
non-Q wave MI and 1 p! (..'~/,) had a Q-wave MI. 17 Pts (32%) requirsdbloed 
transfusions and 8 Pte (15%) required femoral artery repair. There were no 
eubecute slant thrembosis. Follow-up angiagraphy was available in 25 Pts 
(47%) after a mean of 5.6 =1:2.5 months with an average % stunoals of 26 ~- 
30. Angiographic rastenosis (> 50% stenoals) of 1 or more stents was seen in 
6 PIe (24%). At a mean toflow-up of 15 ~- 11 months, 3 Pts (S .'P/o) died. 3 Pts 
(5.7°/o) suffered MI. Revascularization (100% PTCA) wan performed in 17 Pts 
(32%) after a mean of 12 4- 10 months (27°/= target vessel revaScutadzation 
and 11% target lesion revasculadzation). The 2 year survival was estimated 
at 91% and the 2 year revascutadzation-frea survival was 5P/o. 
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In conclusion, 1) Multivessel slanting can be accomplished with a high 
acute success rate and low procedural complications; 2) Despite multivessal 
CAD, no Pt required CABG dudng follow-up; 3) The restenosls rate was 
similar to that of single vessel slanting, and subsequent revescularization 
reflected progression of disease at non-slanted sites. 
9:45 
~ Clinical Application of  Transcatheter Endovaecular 
Graft Placement for  Aortic Aneurysm 
KanJt Inoua" Mitsum Sato, Shunicht Tamaki, Tomoyuki Iwase, 
Tatsuo Fujioka, Ado Yamazato, Shlgem Kube, Yukl Yoshlda, Htay Than 1, 
Masaru Tanaka 1. ~ Talre~a Hospital and Kyolo University Hospital, Kyoto, 
Japan 
A new graft with a delivery system was developed to treat aortic aneurysm 
without surgery. The graft was constructed from Dacron cylinder, and the 
surface of the graft was supported by multiple dngs of extra-flexible wire. 
After the graft was delivered to the predetermined target point through the 
sheath, the graft was allowed to expand by its own flexibility and then pressed 
to the vessel by balloon dilation. The delivept system was easy to use, flexible" 
and small Even if the graft was released in an Inapprepdate position, the 
graft can be moved easily to the optimal position by a carrying wire. After five 
years of experimental studies, transcathster endovascular graft placement 
ustng the graft was paTformed for 14 patients with aortic aneurysm. There 
were 13 men and one woman, aged from 21 to 85 years. The graft with the 
delivery system were successfully inserted percutaneously in6 patients and 
through open artedotomles in 8 patients under local anesthesia. There were 
aortic dissection in 4 patients, abdominal aortic aneuwsm in 4, common 
lilac aneurysm in one, pseudo aneurysm in one, artedovenous fistula in 
one, descending thoracic aneurysm in 2, aortic arch aneurysm in one. The 
graft including 2bifurcated graft was successfully and uneventfully implanted 
in 13 patients. The technical failure occurred in one case. There was no 
precedure-related mo~allty. After the procedure, thrombosis of the aneurysm 
surrounding the graft was complete in 9 patients. The remaining 4 patients 
had either small proximal communication or distal communication. However, 
In these patients, aneurysm was gradually thrombozed in the most parts and 
have shown no evidence of enlargement dudng a mean follow up perioc~ 
of 4.5 months. There were no evidence of severe narrowing, migration, and 
distraction of the graft. Normal flow through the graft have been demonstrated 
up to now. Our early experiences demonstrated the efficacy and the safety 
of transcathetar endovascular graft placement using this new graft. 
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8:30 
Ten Year l~nds In Medical Management and Case 
Patallty in ACUte Myocardial Infarction 
K. Jamrezik, R. Broadhurst, R. W. Parsons, M. S. 1". Hobbe, P. 
L. Thompson. Department o1 Cardiovascular Medicine, Sir Charles 
Gairdner Hospital and Department of Public H~11, University of Western 
Austral/a; Perth - Auslralla 
Previous studies have shown that patterns of management of acute my. 
ecardlal infarction (AMt) can change quite rapidly. We correlated trends in 
management with trends in mortality. The following graph demonsbatee the 
10 year trends in medical management of acute myocardial intacbon in a 
community wide study of 5121 patients aged 25-60 whose symptom onset 
was outside hospital and who were treated in a corenary unit. 
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There were dramatic uptrends in the use of aspidn and thmmbelytto herapy 
and a steady dee in the usa of beta-blockers, declining use of calcium channel 
blockers and anti-arrhythmIc drugs and a re~;ant increase th the use of ACE 
inblblters. 
In 1984/85 the 28 day case fatality was 8.6% declining to 4.6% in 1992/93 
(p < 0,001). This represents an improvement of 40 lives saved in the month 
past-infarction par 1000 patients treated in coronary cam units dudng the 
decade. This Is in excess of any effect which could be attributed to a single 
intepmntion, and is consistent with a benefit from the Combined changes In 
medical management. 
8:45 
~7-~'~ Reperfusion Therapy After Pre-Hoapltsl  Cardiac 
Arrest and Its Influence on Outcome After Acute 
Myocardial  Infarction 
B. Fendlay Stewart, W. Douglas Weaver, Lori S. Parsons, Jenny S. Martin, 
Nathan R. Every. University of Washington, Seattle, WA 
In the MITI registry of patients (pts) with acute myocardial infarction (AMI), 
599 (4.6%) of 12,984 pts had a cardiac arrest pdor to hospital ardvel. Twenty- 
six (4.4%) were In coma on admission. Thrembofyttc therapy was given to 53 
(8.8%) pts, none with coma. Direct PTCA was used In 59 (9.8%), including 3 
pts with coma. 
Age (mean) 





Pro-hospital arrest end AMI AMI w/no arrest 
I g PTCA Ihrombolysis No Rx 
n=59 n-53 n=487 n.log~q=; 
59.5 58.5 67.2 66.1 
10.2 19.9 24.7 20.9 
20.3 20.8 24.7 33.1 
5.1 1.9 19.1 11.3 
24.1 12.5 58.2 9.9 
The mortality in the 23 pts with Coma who did not receive PTC/Z.,lhrembolytfc 
!herapy was 74%; 2 of 310ts wilh coma treated by PTCA also died, 
The mortality for patients with AMI who have be~n resuscitated from 
cardiac arrest is hi'0h. These findings suggest that aggressive reperfuslon 
strategies hould be pursued and their effectiveness tudied, pa~culady in 
pts who are neurologlcagy intact at the time of hospital admission. 
